About Mei He
Mei He, Ph.D. is a tenure-track assistant professor in the Department of Pharmaceutics at the University of Florida in Gainesville. She received her PhD degree from the University of Alberta and postdoctoral training from the University of California, Berkeley from 2008-2012. Dr. He is also the founder of Clara Biotech Inc. and the founder committee for the MidWest 3D technology society. Dr. He received the NIH Maximizing Investigator’s Research Award (MIRA ESI), as well as the LOC Emerging Investigators in 2019, and Outstanding LOC Reviewers in 2018 by the Royal Society of Chemistry. Dr. He also serves the Editorial Board Member for journals Lab on Chip (IF 6.91) and Pharmaceutics (IF 4.8). He publications received Top 100 Read Articles in 2019 from Nature Publsihing group, as well as the SLAS Technology Readers Choice Award in 2018.
Dr. He’s research focuses on precise definition and control of immunity at the molecular level to tissue level, via extracellular vesicles and exosomes -mediated delivery and biological programming strategies, which can be employed in advancing cancer immunotherapy, regenerative medicine, and precision therapeutics. The long-standing interest is to understand immunity communication and delivery for translating into novel therapeutics and treatments against cancers, autoimmune diseases, and infectious diseases which immune responses are the central player.
- 3D Printing and Biomaterials
- Cancer Immunotherapy
- Extracellular Vesicles and Exosomes for Biological Programming and Nanodelivery
- Microfluidic organ on chip
- Regenerative and Precision Therapeutics